Current Trends In Vaccine R&D Show Investments Lacking For TB, HIV, Malaria Products, Duke Analysis Says
Homeland Preparedness News: Financial study reveals global health investment neglects TB, HIV, malaria vaccines
“Despite the deadly reach of diseases like tuberculosis (TB), HIV, and malaria, the world is not likely to develop vaccines to fight them, according to a financial analysis of the current research and development pipeline. The analysis was conducted by Duke University’s Center for Policy Impact in Global Health, following a review of 538 candidate products for 35 neglected diseases. Using that information, they applied a financial modeling tool known as Portfolio-to-Impact (P2I) to estimate the costs and likelihood a product would come to pass…” (Galford, 9/6).